Application of futility analysis to refine jitter recordings in myasthenia gravis

被引:3
|
作者
Narayanaswami, Pushpa [1 ]
Pantoja-Galicia, Norberto [2 ]
Betensky, Rebecca A. [2 ]
Rutkove, Seward B. [1 ]
机构
[1] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Neurol, Sch Med, Boston, MA 02215 USA
[2] Harvard Univ, Dept Biostat, Sch Publ Hlth, Boston, MA 02215 USA
关键词
futility analysis; Jitter recording; myasthenia gravis; Pepe-Anderson method; SFEMG; single-fiber electromyography; SINGLE-FIBER EMG; CONCENTRIC NEEDLE ELECTRODES; EXTENSOR-DIGITORUM-COMMUNIS; REFERENCE VALUES; ELECTROMYOGRAPHY;
D O I
10.1002/mus.22340
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: The current practice of single-fiber electromyography (SFEMG) requires that 20 fiber pairs with normal jitter be collected to exclude myasthenia gravis (MG). We applied principles of futility analysis from clinical trials in an attempt to reduce that requirement. Methods: We utilized conditional power futility analysis to assess the probability of an abnormal 20-pair SFEMG based on ongoing analysis of jitter as each pair is collected. Rules for early test termination in the presence of 0, 1, or 2 abnormal pairs were identified. These rules were then applied to previously collected SFEMG data. Results: SFEMG could be stopped at just 12 pairs if all are normal and at 17 pairs if 1 is abnormal. The rules successfully determined when SFEMG could be stopped in 104 of 106 (98%) studies originally reported to be normal. Conclusions: If the first 12 SFEMG pairs have normal jitter, the study can be terminated and interpreted as normal. Muscle Nerve, 2012
引用
收藏
页码:486 / 491
页数:6
相关论文
共 50 条
  • [41] Population pharmacokinetic analysis of tacrolimus in Chinese myasthenia gravis patients
    Yu-si Chen
    Zi-qi Liu
    Rong Chen
    Lei Wang
    Ling Huang
    Xiao Zhu
    Tian-yan Zhou
    Wei Lu
    Ping Ma
    Acta Pharmacologica Sinica, 2017, 38 : 1195 - 1204
  • [42] Irreversible cochlear damage in myasthenia gravis - otoacoustic emission analysis
    Hamed, SA
    Elattar, AM
    Hamed, EA
    ACTA NEUROLOGICA SCANDINAVICA, 2006, 113 (01): : 46 - 54
  • [43] Comparative analysis of postoperative outcomes of myasthenia gravis with and without thymoma
    王如文
    林一丹
    蒋耀光
    薛志强
    赵云平
    马铮
    Journal of Medical Colleges of PLA, 2005, (05) : 311 - 315
  • [44] Psychometric evaluation of the myasthenia gravis composite using rasch analysis
    Sadjadi, Reza
    Conaway, Mark
    Cutter, Gary
    Sanders, Donald B.
    Burns, Ted M.
    MUSCLE & NERVE, 2012, 45 (06) : 820 - 825
  • [45] The Lived Experience of Myasthenia Gravis: A Patient-Led Analysis
    Nancy Law
    Kelly Davio
    Melissa Blunck
    Dawn Lobban
    Kenza Seddik
    Neurology and Therapy, 2021, 10 : 1103 - 1125
  • [46] Epigenome-wide DNA methylation analysis of myasthenia gravis
    Lin, Jingjing
    Tao, Linshuang
    Deng, Lu
    Zhou, Ruyi
    Lou, Shuyue
    Chen, Songfang
    Chen, Xuanyu
    Lu, Chunxing
    Li, Peijun
    Hu, Beilei
    FEBS OPEN BIO, 2023, 13 (07): : 1375 - 1389
  • [47] Examining the Impact of Refractory Myasthenia Gravis on Healthcare Resource Utilization in the United States: Analysis of a Myasthenia Gravis Foundation of America Patient Registry Sample
    Xin, Haichang
    Harris, Linda A.
    Aban, Inmaculada B.
    Cutter, Gary
    JOURNAL OF CLINICAL NEUROLOGY, 2019, 15 (03): : 376 - 385
  • [48] Myasthenia gravis: The pharmacological basis of traditional Chinese medicine for its clinical application
    Shen Xiaoyue
    Li Yanbin
    BIOFACTORS, 2022, 48 (01) : 228 - 238
  • [49] Turns-amplitude analysis and motor unit potential analysis in myasthenia gravis
    Odabasi, Z
    Kuruoglu, R
    Oh, SJ
    ACTA NEUROLOGICA SCANDINAVICA, 2000, 101 (05): : 315 - 320
  • [50] Stability monitoring of patients with myasthenia gravis using a mobile-based application
    Tafti, Emad Alaei
    Ghazisaeedi, Marjan
    Sarraf, Payam
    CURRENT JOURNAL OF NEUROLOGY, 2023, 22 (01): : 35 - 43